Company profile: Oncodesign Services
1.1 - Company Overview
Company description
- Provider of CRO drug discovery and preclinical services from target identification to IND filing in oncology, inflammation and infectious diseases. Services span small-molecule discovery (PROTAC, molecular radiotherapy; hit finding, lead optimization, candidate generation), preclinical proof of concept (oncology, inflammation, COVID-19; pharmacology imaging, DMPK, microbiome), IND support (toxicology, CMC), bioanalysis, in vitro assays, and pharmaco-imaging.
Products and services
- D-vlop: A regulatory-focused, IND-stage program that constructs toxicology packages, steers CMC development, and architects clinical protocols to advance drug candidates towards clinical trials
- DRIVE-IDDS: An integrated, custom-engineered small-molecule discovery system spanning PROTAC and molecular radiotherapy, delivering hit finding, iterative lead optimization, and preclinical candidate generation for oncology, inflammation, and infectious diseases
- SOLO: A multi-indication, preclinical-stage service architected to deliver proof of concept across oncology, inflammation, COVID-19, with pharmacology imaging integration, DMPK profiling, and microbiome study execution
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Oncodesign Services
Syrrx
HQ: United States
Website
- Description: Provider of drug discovery services leveraging high-throughput structural biology, focusing on drug targets validated in human clinical trials and directing efforts toward therapeutics for metabolic diseases, cancer, and inflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syrrx company profile →
AGC Biologics
HQ: Denmark
Website
- Description: Provider of biopharmaceutical contract development and manufacturing services, including microbial fermentation and mammalian cell culture cGMP manufacturing, process development and scale-up, and production of biopharmaceuticals for pre-clinical, clinical, and market supply. Offers CDMO services for biologics and ATMPs, AGCellerate (DNA-to-IND), lentiviral and AAV vector production, and ADC development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AGC Biologics company profile →
Orange Grove Bio
HQ: United States
Website
- Description: Provider of a preclinical drug investment and development platform focused on reducing drug discovery costs and advancing therapies to clinical trials, offering direct sourcing and comprehensive diligence processes, seasoned operations teams, licensing via academic collaborations, and technologies such as Preservation Bio's platelet additive and Genexys BioMed's gene therapy platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orange Grove Bio company profile →
BioFactura
HQ: United States
Website
- Description: Provider of biopharmaceutical research and manufacturing solutions, offering the StableFast Biomanufacturing Platform to rapidly generate stable NS0 cell lines with a chemically defined production medium, modular expression vectors, and a proprietary growth supplement; development of biosimilars for autoimmune and infectious diseases; antibody-based smallpox and Marburg therapeutics with USAMRIID; and upstream, downstream, and analytical assay services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioFactura company profile →
Ramarketing
HQ: United Kingdom
Website
- Description: Provider of marketing, advertising, public relations, SEO, content creation, graphic design, and consulting services for companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ramarketing company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Oncodesign Services
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Oncodesign Services
2.2 - Growth funds investing in similar companies to Oncodesign Services
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Oncodesign Services
4.2 - Public trading comparable groups for Oncodesign Services
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →